Moderna, Inc.MRNANASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank94
3Y CAGR-27.6%
5Y CAGR+38.5%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-27.6%/yr
vs +337.8%/yr prior
5Y CAGR
+38.5%/yr
Recent deceleration
Acceleration
-365.4pp
Decelerating
Percentile
P94
Near historical high
vs 5Y Ago
5.1x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 212.28% |
| Q3 2025 | 7.83% |
| Q2 2025 | 11.38% |
| Q1 2025 | -225.70% |
| Q4 2024 | 152.68% |
| Q3 2024 | -22.92% |
| Q2 2024 | -28.82% |
| Q1 2024 | -259.00% |
| Q4 2023 | 138.88% |
| Q3 2023 | -74.86% |
| Q2 2023 | 25.31% |
| Q1 2023 | -173.71% |
| Q4 2022 | 559.52% |
| Q3 2022 | -17.11% |
| Q2 2022 | -89.00% |
| Q1 2022 | -16.53% |
| Q4 2021 | 1.04% |
| Q3 2021 | -19.37% |
| Q2 2021 | 36.76% |
| Q1 2021 | 134.99% |
| Q4 2020 | 41.62% |
| Q3 2020 | 3839.26% |
| Q2 2020 | 77.52% |
| Q1 2020 | -10.88% |
| Q4 2019 | 10.53% |
| Q3 2019 | 4.61% |
| Q2 2019 | 22.03% |
| Q1 2019 | -58.13% |
| Q4 2018 | -13.48% |
| Q3 2018 | -66.24% |
| Q2 2018 | 56.68% |
| Q1 2018 | -8.22% |
| Q4 2017 | -141.50% |
| Q3 2017 | 54.16% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |